Business Standard

Lal PathLabs targets leadership position in west India in 5 years

Om Manchanda, MD, Dr Lal Pathlabs said that the contribution of the west zone has gone up from 6 percent in FY15 to 8 percent in FY20 and 15 percent in the first half of FY23

Dr Lal PathLabs: Street worried over rising pressures
Premium

Sohini Das Mumbai
India’s largest private diagnostic player Dr Lal PathLabs is now eyeing a leadership position in the western India market within the next five years. It plans to do so on the back of Suburban Diagnostics, its wholly-owned subsidiary. 

Suburban Diagnostics, which draws almost 70-80 per cent of its revenue from the Mumbai market, has now opened a 13,000 square feet reference laboratory in the city. This is the first Biosafety level-3 (BSL-3) laboratory by any private diagnostic player, the company said. 

Om Manchanda, MD, Dr Lal PathLabs said that the contribution of the west zone has increased from 6 per

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 08 2023 | 10:41 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com